Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
At 12 months, 62 (79%) completed follow-up RPFNA and 61 (78%) completed abdominal fat tissue biopsies.Baseline characteristics of ViDA participants who consented to abdominal adipose biopsy (AB) and/or random fine needle periareolar aspiration (RPFNA)All ViDA trial participants (N = 218)All biopsy participants* (N = 78)Placebo (N = 40)Vitamin D (N = 38) N % N % N % N % Ethnicity Non-Hispanic White19087.2%7292.3%3690.0%3694.7%Non-Hispanic Black146.4%33.9%25.0%12.6%Other (American Indian, Asian)146.4%33.9%25.0%12.6% Education College graduate8539.0%2126.9%1435.0%718.4%Graduate degree7634.9%2937.2%1537.5%1436.8%High school or vocational training73.2%79.0%410.0%37.9%Some college or associate degree5022.9%2126.9%717.5%1436.8% N MEANSD N MEANSD N MEANSD N MEANSDAge (year)21859.65.17859.35.23859.35.64059.34.8Weight (kg)21887.716.37889.616.83889.116.14090.217.7BMI (kg/m2)21832.45.87832.86.03832.85.54032.76.4Waist circumference (cm)218100.112.378101.713.538101.612.340101.814.6Hip circumference (cm)218116.612.278118.013.238118.412.340117.614.1Body fat (kg)21541.610.47642.510.43742.110.33942.810.7Body fat (%)21547.44.97647.75.13747.75.23947.75.1Lean mass (kg)21541.45.87641.75.93741.35.43942.16.4Pedometer steps/day (7 d average)21456293263765324293336574132044049492651Moderate to vigorous activity (min/week)218142143781481433811210540181165Average caloric intake (kcal/day)a 2062004699731946677371971760361920590Relative % calories from fat20633.06.27334.36.83735.47.83633.15.5Relative % calories from protein20617.63.27317.83.63717.13.03618.54.0Relative % calories from carbohydrate20648.37.47347.57.73748.38.03646.57.5Estrone (pg/ml)21844.619.87842.818.23840.618.54045.017.8Estradiol (pg/ml)21815.519.47812.76.23812.46.54012.95.9Leptin (ng/mL)21840.318.97841.219.83841.419.44040.920.3Adiponectin (μg/mL)21812.46.17812.05.43812.45.34011.65.6IL_6 (pg/ml)2177.219.8785.75.8385.75.6405.76.1TNFa (pg/ml)21710.44.7789.94.0389.74.14010.23.9IL_10 (pg/ml)21753.7386.67822.922.83820.217.24025.427.0IL_8 (pg/ml)21713.564.97813.962.03820.988.8407.23.8Insulin (µu/ml)21812.56.87812.66.33812.66.24012.76.5C-reactive protein (mg/ml)2184.78.7783.83.9383.93.9403.74.1Serum 25(OH)D (ng/mL)21821.46.17820.56.53821.66.14019.46.8* 1 participant consented to undergo biopsies but had insufficient sample to be included in analyses and is not included here a Values derived from FFQ were truncated <600 kcal and >4000 kcal
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Within a double-blind, 12-month placebo-controlled randomized trial, we compared 2000 IU/day oral vitamin D3 supplementation (N = 39) vs.
Source: Abstract.
All participants were offered participation in the tissue marker substudy that included collection of breast tissue through RPFNA and an abdominal subcutaneous fat pad biopsy.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women
Study design awaiting verification · NPJ Breast Cancer · 2017
Original publication title
Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women
© The Author(s) 2017
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Adipose tissue is involved in the etiology of postmenopausal breast cancer, possibly through increased sex steroid hormone production, inflammation, and altered adipokines. Vitamin D may affect these pathways but its effect on gene expression in different tissues has not been examined. Within a double-blind, 12-month placebo-controlled randomized trial, we compared 2000 IU/day oral vitamin D3 supplementation (N = 39) vs. placebo (N = 40) on the expression of 5 genes in breast and adipose tissue in overweight/obese postmenopausal women (50 to 75 years).
All participants had serum 25-hydroxyvitamin D (25(OH)D) levels ≥ 10: <32 ng/mL (“insufficient”) and concurrently completed a behavioral weight loss program. Random periareolar fine needle aspiration (RPFNA) and abdominal subcutaneous adipose tissue biopsies were performed at baseline and 12 months. Changes in expression of aromatase (CYP19A1), peroxisome proliferator-activated receptor gamma (PPARG), adiponectin (ADIPOQ), monocyte-chemoattractant protein 1 (MCP-1), and vitamin D receptor (VDR) were analyzed by qRT-PCR. Compared to placebo, 2000 IU vitamin D did not show significant effects on gene expression in breast or adipose tissue.
Replete women (i.e., 25(OH)D ≥ 32 ng/mL; N = 17) showed a small decrease in MCP-1 expression compared to an increase among women who remained ‘insufficient’ despite supplementation (N = 12) (Replete:−1.6% vs. Non-replete: 61.2%, p = 0.015) in breast, but not adipose tissue. No statistically significant differences in gene expression were detected according to degree of weight loss. Vitamin D repletion during weight loss may have different effects on gene expression in breast and adipose tissue. Further research on the localized effects of vitamin D is needed to determine its effect on breast cancer risk.
Vitamin D: Supplementation offers glimmer of benefit
Vitamin D supplementation may help lower the expression of a cancer-associated gene in breast tissue, according to a preliminary trial. Anne McTiernan, Larissa Korde and colleagues at the Fred Hutchinson Cancer Research Center in Seattle, Washington, USA, ran a 12-month randomized clinical study in which 79 overweight postmenopausal women received either daily vitamin D pills or a placebo while concurrently completing a behavioral weight loss program. At the end of the year-long trial, vitamin D seemed to have no effect on the expression of five cancer-linked genes in either breast or fat tissues compared to placebo.
However, women taking the vitamin supplements whose vitamin D levels went up showed a significant drop in their breast tissue in the expression of one cancer-related gene compared to women whose vitamin levels didn’t rise despite the daily pills.
Authors’ abstract
Adipose tissue is involved in the etiology of postmenopausal breast cancer, possibly through increased sex steroid hormone production, inflammation, and altered adipokines. Vitamin D may affect these pathways but its effect on gene expression in different tissues has not been examined. Within a double-blind, 12-month placebo-controlled randomized trial, we compared 2000 IU/day oral vitamin D3 supplementation (N = 39) vs. placebo (N = 40) on the expression of 5 genes in breast and adipose tissue in overweight/obese postmenopausal women (50 to 75 years).
All participants had serum 25-hydroxyvitamin D (25(OH)D) levels ≥ 10: <32 ng/mL (“insufficient”) and concurrently completed a behavioral weight loss program. Random periareolar fine needle aspiration (RPFNA) and abdominal subcutaneous adipose tissue biopsies were performed at baseline and 12 months. Changes in expression of aromatase (CYP19A1), peroxisome proliferator-activated receptor gamma (PPARG), adiponectin (ADIPOQ), monocyte-chemoattractant protein 1 (MCP-1), and vitamin D receptor (VDR) were analyzed by qRT-PCR. Compared to placebo, 2000 IU vitamin D did not show significant effects on gene expression in breast or adipose tissue.
Replete women (i.e., 25(OH)D ≥ 32 ng/mL; N = 17) showed a small decrease in MCP-1 expression compared to an increase among women who remained ‘insufficient’ despite supplementation (N = 12) (Replete:−1.6% vs. Non-replete: 61.2%, p = 0.015) in breast, but not adipose tissue. No statistically significant differences in gene expression were detected according to degree of weight loss. Vitamin D repletion during weight loss may have different effects on gene expression in breast and adipose tissue. Further research on the localized effects of vitamin D is needed to determine its effect on breast cancer risk.
Vitamin D: Supplementation offers glimmer of benefit
Vitamin D supplementation may help lower the expression of a cancer-associated gene in breast tissue, according to a preliminary trial. Anne McTiernan, Larissa Korde and colleagues at the Fred Hutchinson Cancer Research Center in Seattle, Washington, USA, ran a 12-month randomized clinical study in which 79 overweight postmenopausal women received either daily vitamin D pills or a placebo while concurrently completing a behavioral weight loss program. At the end of the year-long trial, vitamin D seemed to have no effect on the expression of five cancer-linked genes in either breast or fat tissues compared to placebo.
However, women taking the vitamin supplements whose vitamin D levels went up showed a significant drop in their breast tissue in the expression of one cancer-related gene compared to women whose vitamin levels didn’t rise despite the daily pills.
Publication and source details
Original title: Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women
Caitlin Mason; Lei Wang; Catherine Duggan; Ikuyo Imayama; Sushma S. Thomas; Ching-Yun Wang; Larissa A. Korde; Anne McTiernan
NPJ Breast Cancer · 2017
© The Author(s) 2017https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T08:07:15.584222+00:00
DOI: 10.1038/s41523-017-0019-5 · PMC5460115